Qualitek Labs Ltd
Founded in 2018, Qualitek Labs Limited provides testing, inspection, homologation, certification, and consulting services.[1]
- Market Cap ₹ 478 Cr.
- Current Price ₹ 410
- High / Low ₹ 459 / 259
- Stock P/E 32.6
- Book Value ₹ 131
- Dividend Yield 0.00 %
- ROCE 11.9 %
- ROE 12.2 %
- Face Value ₹ 10.0
Pros
- Promoter holding has increased by 2.27% over last quarter.
Cons
- Stock is trading at 3.13 times its book value
- Though the company is reporting repeated profits, it is not paying out dividend
- Company might be capitalizing the interest cost
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Services Services Commercial Services & Supplies Consulting Services
Half Yearly Results
Consolidated Figures in Rs. Crores / View Standalone
Profit & Loss
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2021 | Mar 2022 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|
| 6 | 12 | 70 | 125 | |
| 6 | 11 | 54 | 95 | |
| Operating Profit | 1 | 1 | 16 | 29 |
| OPM % | 11% | 10% | 23% | 24% |
| 0 | 0 | 1 | 0 | |
| Interest | 0 | 0 | 2 | 5 |
| Depreciation | 0 | 1 | 4 | 7 |
| Profit before tax | 0 | 0 | 10 | 18 |
| Tax % | 61% | 12% | 26% | 20% |
| 0 | 0 | 8 | 15 | |
| EPS in Rs | 160.00 | 9.13 | 6.31 | 12.53 |
| Dividend Payout % | 0% | 0% | 0% | 0% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | 81% |
| 3 Years: | % |
| TTM: | 77% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | 147% |
| 3 Years: | % |
| TTM: | 133% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| 1 Year: | 38% |
| Return on Equity | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| Last Year: | 12% |
Balance Sheet
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2021 | Mar 2022 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|
| Equity Capital | 0.01 | 0.46 | 10 | 12 |
| Reserves | -1 | 0 | 77 | 141 |
| 11 | 17 | 50 | 93 | |
| 4 | 3 | 21 | 26 | |
| Total Liabilities | 14 | 21 | 158 | 271 |
| 6 | 8 | 92 | 152 | |
| CWIP | 4 | 4 | 16 | 45 |
| Investments | 0 | 0 | 0 | 0 |
| 4 | 9 | 50 | 73 | |
| Total Assets | 14 | 21 | 158 | 271 |
Cash Flows
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2021 | Mar 2022 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|
| 1 | -5 | 10 | 15 | |
| -6 | -2 | -60 | -51 | |
| 5 | 7 | 54 | 37 | |
| Net Cash Flow | 0 | -0 | 4 | 1 |
| Free Cash Flow | -5 | -7 | -13 | -32 |
| CFO/OP | 244% | -363% | 75% | 67% |
Ratios
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2021 | Mar 2022 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|
| Debtor Days | 69 | 67 | 150 | 124 |
| Inventory Days | 70 | |||
| Days Payable | 206 | |||
| Cash Conversion Cycle | 69 | 67 | 150 | -13 |
| Working Capital Days | -701 | -432 | 25 | -10 |
| ROCE % | 6% | 12% |
Insights
In beta| Mar 2024 | Mar 2025 | |
|---|---|---|
| Number of Laboratories Count |
|
|
| Total Employee Headcount Count |
||
| Annual Testing Volume Million Tests |
||
| Collection Centers Count |
||
| Customer Base Count |
||
| Drinking Water Samples (AMRUT Yojna) Count |
||
| National & International Accreditations Count |
||
| Number of PPP and Collaboration Labs Count |
||
| Number of Scientists Count |
||
| Water Samples Tested (Jal Shakti Project) Lacs |
||
Extracted by Screener AI
Documents
Announcements
-
Board Meeting Outcome for Outcome Of Board Meeting Held On June 03Rd, 2026 Under Regulation 30 Of SEBI (LODR) Regulations, 2015
2d - Board approved Rs. 91.31 crore credit facilities from HDFC Bank on June 3, 2026.
-
Intimation Of Appointment Of M/S Finportal Investments Private Limited As Investor Relation (IR) Agency
2 Jun - Qualitek Labs appoints Finportal Investments as IR advisor from 2 June 2026 and sets investor query email.
-
Announcement under Regulation 30 (LODR)-Investor Presentation
21 May - Investor presentation for H2 & FY26 of Qualitek Labs Limited
-
Announcement under Regulation 30 (LODR)-Press Release / Media Release
20 May - Submitted H2 FY26 MD&A; FY26 revenue ₹124.52 Cr, PAT ₹14.66 Cr, and FY27 growth guidance.
-
Audited Standalone And Consolidated Financial Results As On 31.03.2026
20 May - Board approved audited FY26 standalone and consolidated results; net profit rose, with unmodified auditor opinion.
Business Profile[1] Qualitek Labs Ltd. (QLL) provides testing, inspection, homologation, certification, and consultancy services to various industries viz automotive, defense, metals & metallurgy, environment and water, minerals, food & agriculture, pharma & healthcare.